Veille Scientifique

La veille scientifique est un service proposé par la SNFGE. Elle se veut un recensement rapide et assez exhaustif des articles publiés dans les revues majeures (New England Journal of Medicine, Lancet, JAMA, Gastroenterology, Gut, Lancet Oncology, Journal of Clinical Oncology, Hepatology, Journal of Hepatology, Endoscopy, Gastrointestinal Endoscopy...).
 

Patrice PIENKOWSKI
 Coordinateur

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie

Foie/
VB/
Addicto

Gastro/
Procto/

Nutrition
MICI Pancréas
R. FAROUX E. CORON C. SILVAIN P. JOUET S. NAHON V. REBOURS

T. APARICIO
B. DENIS
A. LOPEZ
S. MANFREDI
Y. TOUCHEFEU

E. CHABRUN
A. CULETTO
Y. LEBALEUR
G. PERROD
V. VALANTIN

C. BARRAULT
B. HANSLIK
JL. PAYEN
PE. RAUTOU
D. VALLA

H. DAMON
F. CORDET
V. COSTIL
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
M. FUMERY
D LAHARIE
B. PARIENTE
P. SEKSIK

M. CAMUS-DUBOC
P. DELASALLE
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revue Titre Date Coup de coeur Thématique
Gastroenterology Differences in Alimentary Glucose Absorption and Intestinal Disposal of Blood Glucose After Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy. Jan. 16 4 ♥ Intestin/Nutrition/Troubles fonctionnels
Gastroenterology The Functional Lumen Imaging Probe Detects Esophageal Contractility Not Observed With Manometry in Patients With Achalasia. Jan. 16 3 ♥ Œsophage/Estomac
Gastroenterology Histamine Receptor H1-mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome. Jan. 16 3 ♥ Intestin/Nutrition/Troubles fonctionnels
Gastroenterology Outcomes and Factors Associated With Reduced Symptoms in Patients With Gastroparesis. Jan. 16 3 ♥ Œsophage/Estomac
Journal of the American Medical Association (JAMA) Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial. Jan. 16 3 ♥ MICI
Alimentary Pharmacology & Therapeutics (APT) Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study Jan. 16 4 ♥ MICI
Alimentary Pharmacology & Therapeutics (APT) Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis Jan. 16 3 ♥ MICI
Alimentary Pharmacology & Therapeutics (APT) A validated web-based tool to display individualised Crohn's disease predicted outcomes based on clinical, serologic and genetic variables. Jan. 16 2 ♥ MICI
Gastroenterology Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia. Jan. 16 2 ♥ MICI
Gastroenterology Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 Trial. Jan. 16 2 ♥ MICI
Clinical Gastroenterology and Hepatology Cesarean Section Delivery Is Not a Risk Factor for Development of Inflammatory Bowel Disease: A Population-based Analysis. Jan. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents. Jan. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota. Jan. 16 3 ♥ MICI
Clinical Gastroenterology and Hepatology Features of Patients With Crohn's Disease and Hidradenitis Suppurativa. Jan. 16 3 ♥ MICI
Gut Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial. Jan. 16 3 ♥ MICI
Journal of clinical oncology (JCO) Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial Jan. 16 4 ♥ Cancer colorectal (CCR)
Journal of clinical oncology (JCO) Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study. Jan. 16 4 ♥ Cancer colorectal (CCR)
The Lancet Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials. Jan. 16 3 ♥ Cancer colorectal (CCR)
Annals of oncology Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer Jan. 16 2 ♥ Cancer colorectal (CCR)
Gut Global patterns and trends in colorectal cancer incidence and mortality. Jan. 16 3 ♥ Cancer colorectal (CCR)
Gut Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis. Jan. 16 3 ♥ Cancers autres (hors CCR et CHC)
Gut Risk stratification of individuals with low-risk colorectal adenomas using clinical characteristics: a pooled analysis. Jan. 16 2 ♥ Cancer colorectal (CCR)
The Lancet Oncology Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis. Jan. 16 3 ♥ Cancer colorectal (CCR)
The Lancet Oncology Hyperbaric oxygen for patients with chronic bowel dysfunction after pelvic radiotherapy (HOT2): a randomised, double-blind, sham-controlled phase 3 trial. Jan. 16 2 ♥ Cancers autres (hors CCR et CHC)
The Lancet Oncology Limited screening with versus without 18F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial. Jan. 16 2 ♥ Cancers autres (hors CCR et CHC)

Pages